EARS - Auris Medical Holding Ltd
Previous close
3.045
0 0%
Share volume: 0
Last Updated: Fri 23 Jul 2021 06:00:00 AM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$3.04
0.00
0.00%
Summary score
60%
Profitability
75%
Dept financing
33%
Liquidity
22%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 31-Dec-2014 - 31-Dec-2018
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
139.36%
Return on assets
-23.57%
Return on sales
0%
Return on invested capital
152.12%
Total debt ratio
79.43%
Debt ratio change over timeo
0.66%
Current Ratio
2.89%
Quick Ratio
0%
Cash Position Ratio
2.77%
Short-term ratios 31-Dec-2017 - 31-Dec-2018
The data are presented for the financials results of the quarters of the last year.
Return on equity
127.82%
Return on assets
-27.85%
Return on sales
0%
Return on invested capital
236.97%
Total debt ratio
107.46%
Debt ratio change over timeo
2.05%
Current Ratio
1.05%
Quick Ratio
0%
Cash Position Ratio
0.93%
Last quarter ratios 31-Dec-2018
The data are presented for the financials results of the last quarter.
Return on equity
-100.11%
Return on assets
-6.51%
Return on sales
0%
Return on invested capital
820.28%
Total debt ratio
64.16%
Debt ratio change over time
0.03%
Current Ratio
1.33%
Quick Ratio
0%
Cash Position Ratio
1.18%
Performance ratios (change over 4 years) 31-Dec-2014 - 31-Dec-2018
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
220.87%
Return on assets
-145.4%
Return on sales
0%
Return on invested capital
107.72%
Total debt ratio
65.59%
Debt ratio change over time
0.66%
Current Ratio
1.7%
Quick Ratio
0%
Cash Position Ratio
1.52%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EARS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 139.36% | 0% | 0% | -20.57% |
| Return on assets | -23.57% | 0% | 0% | -7.63% |
| Return on sales | 0% | 0% | 0% | -274.17% |
| Return on invested capital | 152.12% | 0% | 0% | 25.36% |
| Profitability | 75% | 0% | 25% | 4% |
| Total debt ratio | 79.43% | 0% | 0% | 239.95% |
| Debt ratio change over time | 0.66% | 0% | 0% | 31.51% |
| Dept financing | 9% | 0% | 0% | 50% |
| Current Ratio | 1.05% | 0% | 0% | 4.47% |
| Quick Ratio | 0% | 0% | 0% | 4.47% |
| Cash Position Ratio | 0.93% | 0% | 0% | 4.14% |
| Liquididy | 47% | 0% | 0% | 75% |
| Short-term ratios | EARS | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 127.82% | 0% | 0% | -59.24% |
| Return on assets | -27.85% | 0% | 0% | -6.77% |
| Return on sales | 0% | 0% | 0% | -301.25% |
| Return on invested capital | 236.97% | 0% | 0% | 35.93% |
| Profitability | 75% | 0% | 25% | 4% |
| Total debt ratio | 107.46% | 0% | 0% | 146.54% |
| Debt ratio change over time | 2.05% | 0% | 0% | 1.79% |
| Dept financing | 43% | 0% | 0% | 47% |
| Current Ratio | 1.05% | 0% | 0% | 4.47% |
| Quick Ratio | 0% | 0% | 0% | 4.47% |
| Cash Position Ratio | 0.93% | 0% | 0% | 4.14% |
| Liquididy | 11% | 0% | 0% | 75% |